“Explore the significance of ICH E2C, a vital guideline in pharmaceuticals, ensuring continuous safety evaluation throughout a drug’s lifecycle. Learn about the Periodic Benefit-Risk Evaluation Report (PBRER), its impact on regulatory compliance, and how ICH E2C integrates into the comprehensive drug development process. Stay informed about global collaboration efforts and the evolving landscape of safety data management in the pharmaceutical industry.”